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Abstract 
 
Background: A new development in the field of telehealth is the use of 
mobile health technologies (mhealth) to assist patients in the recording 
and tracking of medical information. Mhealth appears particularly 
advantageous for conditions that require intense and ongoing 
monitoring such as diabetes, and where people are of working age and 
not disabled. This review aims to evaluate the evidence for the 
effectiveness of mhealth interventions in diabetes management on 
glycosylated haemoglobin (HbA1c).  
 
Methods: A comprehensive search strategy was developed and applied 
to eight electronic databases to identify studies investigating the clinical 
effectiveness of mobile-based applications allowing patients to record 
and send their blood glucose readings to a central server. The eligibility 
of 8543 papers was assessed against the selection criteria, and 24 
papers were reviewed. All studies reviewed were assessed for quality 
using a standardized quality assessment tool.  
 
Results: Results for patients with type 1 and type 2 diabetes were 
examined separately. Study variability and poor reporting made 
comparison difficult, and most studies had important methodological 
weaknesses. Evidence on the effectiveness of mhealth interventions 
for diabetes was inconsistent for both types of diabetes and remains 
weak. 
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Introduction 
 
Telemonitoring refers to the recording and tracking of medical data by 
patients and health care professionals (HCPs) at a distance. For the 
management of chronic conditions such as diabetes that require 
intensive daily monitoring and behavioural adjustment, this method of 
care may be particularly relevant. Diabetes self-management includes 
self-monitoring of blood glucose (SMBG) readings, medication taking, 
exercise, dietary management, and foot care. Evidence suggests 
SMBG alone may be of limited clinical effectiveness. This may be 
because patients are unable to interpret results and hence make 
adjustments to self-care1,2. By providing patients with the tools needed 
to review, interpret data, and receive feedback, telemonitoring could 
facilitate self-management. 
 
Until recently, telemonitoring applications relied on home- based 
technologies but with mobile devices patients can transmit data in real-
time, at any time and in any place. This also means feedback can be 
received when it is most relevant. The ubiquitous nature of these 
wireless technologies is an important development, with potential to 
impact upon diabetes management.  
 
A number of systematic reviews have examined the use of 
telehealth in diabetes looking at a range of technologies, including fixed 
and mobile equipment 3-5. Where reviews focused only on mobile 
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platforms a variety of interventions were included, for example 
interventions aiming to increase peer support, educate, or remind 
patients of appointments or self-care activities6,7,8,9. Some reviewed 
both paediatric and adult samples, despite their differences in the 
management of diabetes and use of technology. Inclusive reviews are 
useful to gain a better understanding of ongoing research in the field. 
When looking at clinical effectiveness however, reviews that focus on 
specific interventions or intervention components are needed for 
conclusions to be precise and reliable. 
 
This reviews aims to examine the evidence for the clinical 
effectiveness (HbA1c) of mobile telemonitoring to support diabetes 
management in adult patients. It focuses on interventions including the 
transfer of data to a web server to receive feedback. 
 
Methods 
 
Search strategy 
Six electronic databases were searched in August 2009, with a 
subsequent update in January 2012. The search combined diabetes, 
mobile platform terms: “HbA1c”, “metabolic control”, “glycaemic 
control”, “glycosylated haemoglobin”, “glycated haemoglobin”, 
“diabetes complications”, “blood glucose”, “hypoglycaemia”, “plasma 
glucose”, “insulin”, “mobile phone”, “cell phone”, “PDA”, “personal 
digital assistant”, “personal smart assistant”, “pocket computer”, 
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“pocket PC”, “short message service”, “SMS”, “text messaging”, 
“wireless”, “iphone”, “smartphone”, “electronic diary”, “real-time”, 
“pager”.  
 
Inclusion and exclusion criteria 
Studies included for review investigated the clinical effectiveness 
of interventions requiring patients to transmit blood glucose (BG) 
readings to an online server via a mobile device. Studies involving an 
adult population (>18 years) with type 1 or type 2 diabetes were 
eligible. Glycosylated haemoglobin (HbA1c) had to be a clinical 
outcome. Case studies, papers with simulated HbA1c data, devices 
designed for use by HCPs, and studies with a sample consisting of 
more than 20% insulin pump users were excluded. Only English 
language papers were reviewed.  
 
Data extraction  
A data extraction form was developed, piloted and used to 
extract data by JB. Authors were contacted for clarification when 
needed. 
 
Quality assessment 
An adapted version of the McMaster University quality 
assessment tool10 was used to assess papers. Using the tool and its 
dictionary, studies were rated as poor, moderate, or strong. Ten areas 
were covered: selection bias, research objectives, study design, power, 
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blinding, data collection methods, withdrawals and dropouts, 
intervention integrity, suitability of analyses and of interpretation of 
findings. Studies that were not RCTs or controlled trials were assessed 
against nine of these areas as blinding was not relevant. To achieve a 
“strong” rating, RCTs and controlled trials had to be rated “strong” in at 
least six of the ten areas and have no areas rated “weak”. Other study 
designs required five or more strong ratings out of nine and no weak 
ratings. 
 
Results 
 
Study selection 
Paper selection was conducted independently by two of the 
authors. Disagreements were resolved through discussion until 
consensus was reached. Figure 1 illustrates stages of the paper 
selection process for the 2009 search and 2012 update. Titles and 
abstracts were screened, leading to the review of a total of 146 full 
texts. A total of 24 publications matched the selection criteria. Three 
additional papers11-13  were used for data extraction purposes; they 
provided no additional clinical data but further information on the 
methodology or intervention tested in 2 of the reviewed studies. 
 
The 24 identified publications described 20 studies. Seven 
papers15-21 published by the same group of authors evaluated the same 
intervention with some appearing to describe the same sample. The 7 
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papers were independently examined by two authors and divided into 
three different studies. One (2 papers19,21) focused on an intervention 
delivered to obese patients. A second (4 papers16-18,20) evaluated the 
same intervention in a population not restricted to obese patients. Each 
of these four articles presented different follow-up periods and one 
paper presented a subgroup analysis based on baseline HbA1c. 
Finally, a third study (1 paper15) used a single group before and after 
design. In this review, all papers referring to what was defined above 
as one study are grouped.  
 
Description of included studies 
 Papers were published between 2002 and 2011. Studies were 
conducted in Asia (n=8), Europe (n=8), and the US (n=3); one was a 
multinational trial. Seven studies involved a population with type 1 
diabetes, 11 with type 2. Two studies included a mixed population, but 
as the percentage with type 1 was minimal (8% and 16%) they were 
grouped with studies on type 2.  
 
Table 1 and table 2 summarize intervention components. Tables 
3 and 4 summarize study and participant characteristics; they include 
the quality assessment results. These results suggest that overall 
quality was poor. Sixteen studies were rated weak, three moderate and 
one strong.  
 
Baron, Justine, Hayley McBain, and Stanton Newman. "The impact of mobile 
monitoring technologies on glycosylated hemoglobin in diabetes: a systematic 
review." Journal of diabetes science and technology 6.5 (2012): 1185-1196. 
 
Page 6 of 33 
 
Of the 20 studies 12 were randomized controlled trials (RCT) of 
which one was a four group cluster RCT, 1 was a controlled trial, 2 
were crossover studies and 5 were single before and after designs. Of 
the 15 two group studies, nine evaluated mhealth compared to 
standard care, and six with another intervention. This was either 
another mhealth intervention, a web, or a fax/phone based intervention, 
pedometer monitoring or diabetes education. The four group RCT 
compared both mhealth to standard care and different mhealth groups 
with varying HCP access to patient data.  
 
The mhealth interventions evaluated were similar across type 1 
and type 2 diabetes with the exception of dietary interventions which 
occurred in type 1. Three of the type 1 diabetes studies had a specific 
focus on dietary management. The purpose of these mhealth systems 
was to provide patients with support in calculating the appropriate 
insulin dose to match food consumed. Participants were required to 
transmit information on meal content and received automated feedback 
on proteins, carbohydrates (CHO), calories and fat intake. An 
algorithm-based insulin dose was suggested in two of these studies. Of 
these one study investigated whether the use of such a system could 
reduce the amount of hours usually spent on CHO counting education; 
the mhealth group received a shortened version of the standard CHO 
education and used the device whilst the control group received the full 
version. 
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 In the remaining studies on both type 1 and type 2 diabetes 
participants transferred a combination of one or more of the following to 
a web server: BG readings, blood pressure readings, weight, exercise, 
diet, medication, free text, and/or their level of well-being. Reminders to 
transmit were part of the intervention protocol in seven studies. Of 
these two25 were on type 2 diabetes; in one25 patients were reminded 
to transmit when there were too few readings for clinical judgement, 
and in another if less than three readings were sent daily (REF 
KOllman). In some studies patients who did not transmit sufficient data 
were withdrawn(ref). 
 
HCP feedback was provided in the majority of studies and 
included treatment recommendations, encouragements, reminders, 
advice, and corrections to lifestyle. In some cases only patients with an 
out of range BG reading or high-risk profiles were contacted, whilst in 
others all participants received feedback regardless of their BG values. 
Automated feedback was an intervention component in nine studies, 
and was delivered via text message, on an accompanying patient web 
portal or via letter. Graphical feedback was provided in seven studies 
and was a representation, sometimes colour-coded, of BG values over 
time. This was offered in addition to HCP feedback in 5 studies. Only 
one study included both automated text and HCP feedback. It suggests 
that providing automated text feedback is considered as a good 
alternative to HCP feedback when resources are limited.  
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Clinical effectiveness of studies on type 1 diabetes 
 
For studies evaluating a diet focused intervention results were 
mixed. The single group trial27 which was rated poor quality failed to 
find any significant change in HbA1c post intervention. The sample size 
remained small (n=41) making the generalizability of the findings 
limited and authors failed to report the number of participants 
completing the study. In addition, the frequency at which HCPs 
reviewed patient data and provided feedback was not specified. When 
the mhealth technology plus a short version of standard CHO 
education was compared to standard CHO education in the 
multinational RCT28 no difference was found between groups but 
significant reductions in HbA1c were observed at 6 months in both 
groups. Although results are useful in suggesting mhealth could 
effectively replace part of the standard CHO counting education, this 
study was rated of moderate quality. Little detail was provided on the 
content of the education sessions which makes it difficult to identify 
which intervention components are necessary for intervention 
effectiveness. Authors also failed to report outcome differences 
between countries although variations in dietary habits and intervention 
delivery (despite efforts to standardize) might have influenced results.  
Finally, the remaining dietary intervention compared twice weekly 
transmission of BG and diet information with feedback from a HCP to 
standard care in a crossover trial29. A significant reduction in HbA1c 
was reported only in the group with a significantly shorter diabetes 
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duration (5.3 years versus 11.8), suggesting this tool might be 
particularly useful for patients recently diagnosed. This study however, 
was also rated as poor quality. It included only 20 participants, and 
there was no washout period between study periods to avoid carry over 
effects.  
 
Results of studies on non dietary interventions were inconclusive 
with 222,30 of the 4 studies supporting the effectiveness of mhealth. 
Monitoring patients via mhealth led to significant improvements in 
HbA1c after 3 months in a before and after study22 involving 
submission of data via mobile phone and access to graphics via a web 
portal. Participants were expected to transmit data at least 3 times 
daily; the inclusion criteria however did not require patients to have this 
monitoring pattern at the time of enrolment. Hence, improvements in 
HbA1c may be the result of changes in self-monitoring patterns. A 
RCT30 comparing mhealth with either intensive graphical feedback and 
nurse support or minimal graphical feedback only, found significant 
improvements in HbA1c in both groups at 4 and 9 months. This 
suggests significant changes can occur regardless of the intensity of 
the graphical feedback provided and HCP input may not be an 
essential ingredient to intervention success. Although the study had a 
larger sample size than many of the studies reviewed, it was slightly 
below the number of participants required for adequate power. Authors 
also failed to report ifoutcome assessors wereblinded . Interestingly the 
response rate in this study was relatively low (52%) despite recruiting 
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an age group (18-30 years) who maybe keen to use technology. 
Finally, no significant clinical changes were observed in the two 
remaining studies examining transfer of BG readings via PDA and 
mobile-phone plus HCP and graphical feedback 25,31. Unlike the 
majority of studies reviewed patients were limited to transferring BG 
readings only in these two studies. Asking patients to transfer more 
information may increase awareness and understanding of the 
relationship between BG readings and lifestyle factors, making it 
possible for patients to act upon them in an effective way. In addition 
Gomez and colleagues (2002) asked patients to transmit BG readings 
fortnightly which is considerably less frequent than other studies. 
Research regarding optimal transmission frequency is however lacking. 
In terms of methodological quality, intervention participants in the study 
by Vahatelo et al (2004) received twice as many testing strips as 
control participants; this enabling increased monitoring and thereby 
introducing bias. In addition the trend towards HbA1c deterioration in 
both groups was linked to the calibration differences between the 
machines used to test HbA1c. This suggests lack of methodological 
rigour in the conduct of the study, potentially biasing results.   
 
Clinical effectiveness of studies on type 2 diabetes 
 
In the studies published by the same group of authors the 
intervention included transmission of BG readings by mobile-phone and 
weekly text message recommendations. In the 12 week program using 
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a single group design15 a significant pre to post reduction in HbA1c was 
found. Although the reduction from baseline to follow-up was clinically 
significant (1.1%), the sample size was small. With 26% (n=12) of the 
sample excluded from the analysis, it would have been particularly 
relevant to investigate differences between patients who did not 
engage with the equipment or dropped out and those who completed 
the research. However, such analyses were not reported by the 
authors, nor were reasons for non-transmission of patient data. When 
applied to patients with a BMI >2319,21  this intervention led to a 
significant improvement in HbA1c in the intervention group compared 
to the control group. Following a group of participants longitudinally16-
18,20 significant differences between the intervention and control groups 
were found at 3, 9 and 12 months. In a sub-group analysis16 significant 
improvements in HbA1c were observed at 3 months for intervention 
group participants with a baseline HbA1c of ≥7% but not for the control 
group participants with the same baseline HbA1c. As might have been 
expected however, no significant improvement was noted in those 
already well controlled (HbA1c<7%). In fact these participants 
maintained good glycaemic control, whereas participants in the control 
group starting the study with a HbA1c of <7% deteriorated significantly. 
These results suggest mhealth is effective for people with poorly 
controlled diabetes, whilst also being more effective than standard care 
in helping people with well controlled diabetes maintain glycaemic 
control.  
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Of the 10 remaining studies seven found mhealth to be 
significantly more effective than other telehealth interventions and 
standard care. Two single group studies14,37 led to similar and 
significant improvements in HbA1c at 3 and 6 months, particularly so 
for those with a baseline HbA1c of ≥ 7.0%37. In a trial26 evaluating a 
system that provided patients with an insulin dose adjustment based on 
fasting BG readings, overall a clinically significant reduction in HbA1c 
was observed, but the reduction was significantly greater in the 
intervention group. Two RCTs33-35 found significant reductions in HbA1c 
for the mhealth group. One compared the mhealth intervention to a fax 
or telephone based intervention. In this study however the control 
group phoned or faxed in their BG readings fortnightly until these were 
stable. It was unclear whether HCP feedback was provided to this 
group and no criteria defined a stable BG readings pattern. The other 
RCT compared mhealth to standard care33. Improvements were 
significant at six months, but were not at 12 months.therefore, 
suggesting  only short term effectiveness.. Finally, the 4 group RCT36 
found significantly greater reductions in HbA1c at 12 months in 2 of the 
3 active treatment groups compared to the control group after 
controlling for baseline HbA1c. Unlike Rodriguez-Idigoras et al (2009) 
these between group differences were still significant at 12 months. 
Interestingly there were no significant differences between the three 
active treatment groups although these differed in the level of access 
HCPs had to patient data. Similar to Farmer and colleagues (2005) in 
type 1 diabetes, it appears the key and active driver to success may  
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be the transmission of patient data, regardless of whether that data is 
reviewed by HCPs or used to provide feedback. 
 
The remaining 323,24,32  RCT studies failed to find mhealth to be 
more effective than standard care or other telehealth interventions. 
These included mhealth and pedometer monitoring compared to 
standard care with pedometer monitoring32, HCP feedback via letter 
including amalgamated readings and treatment recommendations to 
standard care24, and a computer versus a mhealth intervention23. For 
Faridi et al (2008)32, this is unsurprising considering the low levels of 
adherence to protocol amongst 15 intervention group patients. Only 2 
patients were completely adherent and transmitted readings daily, 
whilst 9 patients were found to either transmit only for a week (n=4) or 
not at all (n=5) and the remaining 4 only for 1-2 months out of 3. 
Important methodological issues led to this study being rated as poor. 
For example the control group wore pedometers as part of the 
objective assessment of physical activity. Although this was not 
intended as an intervention, reviewing daily step counts could have 
influenced participants’ levels of exercise and biased results. 
Istepanian and colleagues 24 found mhealth to be ineffective in 
reducing HbA1c with patients receiving feedback in a letter format. 
Unfortunately authors did not report the frequency at which letters were 
sent to patients or the type of treatment recommendations made. The 
immediacy of feedback displayed via mobile platforms as a result of 
data transmission may be more likely to facilitate data interpretation 
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and promote active and prompt reactions to physiological states. The 
third RCT23 did find significant improvements in HbA1c for both mhealth 
and a computer-based web monitoring intervention however 
differences between groups were not significant. Both groups improved 
significantly and similarly despite the computer group being able to 
transfer considerably more diabetes-related information than the 
mobile-phone group. The portability of the device which may act as a 
reminder and prompt to self-care may therefore be as effective as 
being able to provide more information. The behavioural mechanisms 
involved in fixed and mobile technology may differ and require further 
examination. 
 
Discussion 
 
This systematic review summarizes the evidence base for the 
clinical effectiveness of mhealth interventions in which patients transmit 
diabetes related information to receive automated text, graphical and/or 
HCP feedback. Systematic searching found 13 studies on type 2 
diabetes and 7 on type 1 diabetes. None of the studies reviewed found 
mhealth to be harmful. Overall the findings from the studies reviewed 
are somewhat mixed, but do appear to be more consistently positive for 
studies in type 2 diabetes as was reported by Azar and colleagues39. 
Ten of the thirteen studies in type 2 diabetes and four of seven studies 
on type 1 found mhealth to lead to benefits. Studies without HCP 
feedback led to improved HbA1c, suggesting HCP feedback might not 
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be necessary for intervention success. The recording and tracking of 
data could be the key factor for increasing patients’ awareness, 
understanding, and motivation to self-manage. Knowledge that the data 
is accessible to HCPs may also be an incentive to adhere to a regimen. 
The graphical and automated text feedback might also be an effective 
incentive to engage patients. It may help patients identify relationships 
between their lifestyle and BG patterns. Future research needs to 
determine which patients benefit most from HCP feedback and which 
patient characteristics predict intervention effectiveness. This will guide 
future mhealth deployment tactics and increase cost-effectiveness. 
 
The methodological quality of the reviewed studies was poor, 
with many involving small sample sizes, no power calculations, and 
poor study designs. Many studies excluded patients who failed to 
engage with the devices from the analysis; this implies they assessed 
intervention efficacy and not effectiveness. If a ‘per protocol analysis’ 
rather than an intention to treat analysis is presented as might be the 
case especially with studies with smaller sample sizes, this should be 
supplemented by an analysis of differences between completers and 
those that dropouts along with a discussion on the possible implications 
and effects of the missing participants. Some of these criticisms reflect 
the observations made by Whitten and colleagues in their review of the 
methodology adopted in telehealth research40. In addition, poor 
reporting in these studies made interpretations difficult; additional 
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paper, web pages, or diagrams should be made available to ensure 
transparency.  
 
Finally, the costs incurred in the delivery and running of these 
telemonitoring interventions was not discussed in this review. Without 
this information, it remains impossible to know whether implementing 
such services is cost-effective.  
 
This systematic review has limitations. It does not consider 
research exclusively on specific subgroups such as pregnant women or 
insulin pumps users. Non-English language papers were not reviewed, 
and a publication bias could have occurred since grey literature was 
not searched.  
 
In view of the considerations raised above and their implications 
on the interpretation of study results, this review cannot reliably 
conclude on the clinical effectiveness of mhealth interventions for 
diabetes management. Results do show potential for beneficial change 
but higher quality studies with better standard of reporting are urgently 
needed and will provide a strong evidence-base for policy makers. 
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Figure 1. Study selection process for the 2009 search and 2012 update 
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Table 1. Intervention components of studies on type 1 diabetes 
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Table 2. Intervention components of studies on type 2 diabetes 
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Table 3. Study and participant characteristics (type 1 studies) 
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Table 4. Study and participant characteristics (type 2 studies) 
 
